Loading company…
ID 400243036 · FY 2019–2024 · 6 years
კომპანიის ძირითად საქმიანობას წარმოადგენს ფარმაცევტული პროდუქციით საბითუმო ვაჭრობა.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 362 | 5,766 | 4,174 | 4,749 | 9,205 | 7,583 | +83.7% |
| Total Non-Current Assets | 1,379 | 2,021 | 6,614 | 5,601 | 5,601 | 10,290 | +49.5% |
| TOTAL ASSETS | 1,741 | 7,787 | 10,788 | 10,349 | 14,805 | 17,873 | +59.3% |
| Total Current Liabilities | 193 | 934 | 1,658 | 1,136 | 1,374 | 309 | +9.9% |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | |
| TOTAL LIABILITIES | 193 | 934 | 1,658 | 1,136 | 1,374 | 309 | +9.9% |
| Total Equity | 1,549 | 6,853 | 9,130 | 9,213 | 13,432 | 17,563 | +62.5% |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | |||||||
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cash & Equivalents | 76 | 40 | 254 | 291 | 525 | 192 | +20.3% |
| Net Debt | -76 | -40 | -254 | -291 | -525 | -192 | +20.3% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.